AN EXPERIENCE IN APPLYING SERA TO COUNTER MALIGNANT NEOFORMATIONS UNDER EXPERIMENTAL CONDITIONS.
D000818:Animals; D000970:Antineoplastic Agents; D001323:Autoantibodies; D002284:Carcinoma, Brown-Pearce; D002286:Carcinoma, Ehrlich Tumor; D006736:Horses; D006821:Hyaluronoglucosaminidase; D007106:Immune Sera; D007116:Immunization, Passive; D007680:Kidney Neoplasms; D008113:Liver Neoplasms; D051379:Mice; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000209:etiology*; D009374:Neoplasms, Experimental; D010600:Pharmacology; D011817:Rabbits; D012106:Research; D012756:Sheep
D000970:Antineoplastic Agents; D001323:Autoantibodies; D007106:Immune Sera; D006821:Hyaluronoglucosaminidase
ANTINEOPLASTIC AGENTS; AUTOANTIBODIES; CARCINOMA, BROWN-PEARCE; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; HORSES; HYALURONIDASE; IMMUNE SERUMS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; MICE; NEOPLASM ETIOLOGY; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; RABBITS; SEROTHERAPY; SHEEP